ACADIA Pharmaceuticals Inc. (OQ:ACAD)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ACAD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 8/20 Jan 7/20 Brege Laura Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Jan 8/20 Jan 7/20 Brege Laura Direct Ownership Common Stock S - Open market or private sale -10,000 $42.19
Jan 8/20 Jan 7/20 Brege Laura Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $1.75
Jan 8/20 Jan 6/20 Yang Michael J. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 10,889  
Jan 8/20 Jan 6/20 Yang Michael J. Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 39,516  
Jan 8/20 Jan 6/20 Ridloff Elena Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 10,889  
Jan 8/20 Jan 6/20 Ridloff Elena Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 39,516  
Jan 8/20 Jan 6/20 Kim Austin D. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 6,533  
Jan 8/20 Jan 6/20 Kim Austin D. Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 23,709  
Jan 8/20 Jan 6/20 Stankovic Srdjan R. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 21,777  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ACAD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 8/20 Jan 6/20 Yang Michael J. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 10,889  
Jan 8/20 Jan 6/20 Yang Michael J. Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 39,516  
Jan 8/20 Jan 6/20 Ridloff Elena Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 10,889  
Jan 8/20 Jan 6/20 Ridloff Elena Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 39,516  
Jan 8/20 Jan 6/20 Kim Austin D. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 6,533  
Jan 8/20 Jan 6/20 Kim Austin D. Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 23,709  
Jan 8/20 Jan 6/20 Stankovic Srdjan R. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 21,777  
Jan 8/20 Jan 6/20 Stankovic Srdjan R. Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 79,031  
Jan 8/20 Jan 6/20 Davis Stephen Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 38,110  
Jan 8/20 Jan 6/20 Davis Stephen Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 138,304  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ACAD

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)